Sangamo Therapeutics Inc. buy Barclays PLC
Start price
14.11.24
/
50%
€2.12
Target price
14.11.25
€8.52
Performance (%)
-81.54%
End price
15.11.25
€0.39
Summary
This prediction ended on 15.11.25 with a price of €0.39. The BUY prediction by Barclays_PLC for Sangamo Therapeutics Inc. performed very badly with a performance of -81.54%. Barclays_PLC has a follow-up prediction for Sangamo Therapeutics Inc. where he still thinks Sangamo Therapeutics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | 3.988% | 3.988% | -62.138% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % |
Comments by Barclays_PLC for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target raised by analysts at Barclays PLC from $3.00 to $9.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.41
14.05.25
14.05.25
€4.47
14.05.26
14.05.26
-16.24%
17:56
17:56
